Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence

被引:0
作者
Richard E. Gliklich
Michelle B. Leavy
机构
[1] OM1,
[2] Inc,undefined
[3] Harvard Medical School,undefined
来源
Therapeutic Innovation & Regulatory Science | 2020年 / 54卷
关键词
21st Century Cures Act; medical product evaluation; electronic health records; product registries; disease registries;
D O I
暂无
中图分类号
学科分类号
摘要
The use of real-world data and real-world evidence to inform health care decisions is increasing. Yet, the variable quality of these data and the lack of widely-accepted criteria by which to assess quality create uncertainty about how and when to use these data and the associated evidence in decision making. Patient registries are an important source of real-world data and real-world evidence. The good practices and evaluation criteria developed for patient registries are highly relevant to real-world data and real-world evidence and offer a foundation for a unified set of quality criteria that can be applied across sources of real-world data and real-world evidence intended for use in medical product evaluation.
引用
收藏
页码:303 / 307
页数:4
相关论文
empty
未找到相关数据